inmed-pharmaceuticals

ATERA Signs R&D Agreement with InMed

Vancouver, BC – July 10, 2017 – InMed Pharmaceuticals, Inc. (“InMed” or the « Company ») (CSE: IN; OTCQB: IMLFF), a biopharmaceutical company specializing in the research and development of novel, cannabinoid-based drug therapies, is pleased to announce it has entered into a research and development collaboration with ATERA SAS of France, a leading tissue engineering company…

collaboration-atera-cell-systems

CellSystems Biotechnologie Vertrieb GmbH and ATERA SAS announce a close collaboration

CellSystems Biotechnologie Vertrieb GmbH (Troisdorf, Germany) and ATERA SAS (Villeneuve-Loubet, France) announce a close collaboration for the commercialization of the epiCS® human skin models, including human epidermis, tanned epidermis and full thickness skin. Both companies will work together to boost the sales of the epiCS® skin models and related products as well as testing applications by co-marketing cross sectorial.

3D-Cell-culture-2016_Freiburg_Germany_April_19_21

3D Cell culture 2016: How close to ‘in vivo’ can we get: Models, Applications & Translation. Freiburg, Germany April 19-21, 2016

ATERA’s CSO Dr. Florian Groeber speak on the use of complex tissue engineered skin models and impedance spectroscopy as new tools for hazard identification and efficacy testing.  These questions will be addressed – and answered – at 3DCC 2016: What is successfully applied? What is in development? Where are still gaps? The conference will highlight successful…

Vitroscreen Symposium ‘Mucosal Immunity and In Vitro Science’

May 19, 2016, Milan, Italy: Vitroscreen Symposium ‘Mucosal Immunity and In Vitro Science’

At the occasion of the 15th anniversary of the Contract Research Organization ‘VitroScreen’, a scientifc symposium will be organized on May 19, 2016 in Milan, Italy, focussing on the use of 3D human tissue models  as predictive and innovative experimental models for pharma, cosmetic and food supplement industry. Expert speakers will present relevant topics and…

4th-International-Cosmetic-Innovation-Days-‘Cosminnov

4th International Cosmetic Innovation Days ‘Cosminnov’, Orleans, France May 24-25, 2016

At the occasion of the 4th International Cosmetic Innovation Days ‘Cosminnov’, ATERA’s CEO Dr. Bart De Wever will give an oral presentation  on the use of the company’s unique vascularised skin models for hazard identification and efficacy testing. In additionally a new technology called impedance spectroscopy will be presented as a new means to evaluate mildness of…

11th International Conference and Workshop on Biological barriers

11th International Conference and Workshop on Biological barriers, Saarbrücken, Germany March 7-9, 2016

At the occasion of the 11th International Conference and Workshop on Biological barriers organized by the Univ of Saarbrücken, ATERA’s CSO Dr. Florian Groeber will give an oral presentation on March 8 at 16.00h on the use of complex tissue engineered skin models and impedance spectroscopy as new tools for hazard identification and efficacy testing. The  biennial Conference and…